Hello! Thanks so much for your reply.
I was told (and believe) I have HSV 2. They told me that on the phone; it was confirmed through swab. I have never taken a blood test or been tested for it otherwise.
I've read mixed reviews about HSV1 providing protection-- because some studies seem to allude that it does. If this is true- it makes sense because I never had chicken pox or HSV1 in my entire life so I think it explains why I caught HSV2 from a one night experience (just my luck and just my own theory)
Although I still experience twitching in my body -- I feel happy that the valtrex every other day suppresses it. But I do wonder, because I'm experiencing such reduced symptoms; if my shedding is reduced too. I doubt it but just a thought.
Anyways - I can live with condoms but I don't want to.. so I'm hoping for some guidance
This is no great surprise that HSV is pushed back in ExcisionBio's pipeline. I'd be surprised if it isn't pushed back again.
The chart they put out is painfully uninformative. Sloppy. And that's a red flag in and of itself.
My guess is that those arrows are progress rather than efficiency, but it's not completely clear. But if a scientific company can't get this chart right, then I really wonder what other mistakes they are making.
I don't have a ton of confidence in this. But we'll see. I'm glad that it seems they are trying to do something. I think CRISPR could be a solution to HSV (some kind of solution). But I question whether it will be ExcisionBio that makes it in the end.
Good to know. I don't think this is a listed company, but from what I've read, they've gotten decent funding. Around $70 million. Most of that probably won't go to HSV research, but it's good they have some money.
By comparison, ExcisionBio has raised $10 million.
The fact that Admedus is farming this out, kind of tells you it's a long shot at best. It's good that it hasn't been abandoned. But I'm doubtful much will come of this. But maybe new knowledge about what doesn't work will come, and that's always helpful.